The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Amir Ben-Tov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Eye Diseases, Inflammatory Bowel Diseases, Crohn Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Ocular manifestations (OMs) in patients with inflammatory bowel disease (IBD) are uncommon, particularly in children. We aimed to explore the prevalence and characteristics of IBD-associated OM in a large cohort study.
Methods
A cross-sectional study was performed using the Maccabi Healthcare Services (MHS) database. The eligible population included all patients diagnosed with IBD as children (<18 years) between January 2005 and July 2023.
Results
Out of 2567 children with IBD (males 55%, Crohn’s disease 64%), 78 (3%) were diagnosed with OM at any time during the disease course. In 54 patients (69%), the ocular disease occurred after IBD diagnosis with a median time of 2.6 (0.47-7) years between the 2 events, whereas in 24 patients (31%), ocular involvement preceded IBD diagnosis with a median time of 2.1 (0.6-5.7) years. The presence of ocular involvement was associated with increased usage of systemic corticosteroids (P < .001) and biologic agents (P = .04). There were 55 patients with ocular involvement during childhood who were ever diagnosed with IBD. In this population, ocular involvement was also associated with increased usage of systemic corticosteroids (P < .001). The prevalence of OM among patients with IBD did not change significantly over time (P = .75), with a prevalence of 2.3% at the end of the study period.
Conclusions
The prevalence of ocular involvement in children with IBD is rare and steady; it is also associated with a greater usage of systemic corticosteroids and biologic agents, potentially representing a more severe disease course.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel.
- Pediatric Gastroenterology Institute, Dana-Dwek Children's Hospital, Tel Aviv, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- IBD Center, Division of Gastroenterology, Rabin Medical Center, Petah Tikva, Israel.
- Ophthalmology Institute, Assuta Medical Center, Tel Aviv, Israel.
- Faculty of health sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
ORCID-Profile: Amir Ben-Tov, Henit Yanai, Amit Assa
Zitieren
APA
Ben-Tov, A., Achler, T., Patalon, T., Gazit, S., Yanai, H., Shulman, S., & Assa, A. (2025). The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae160
Vancouver
Ben-Tov A, Achler T, Patalon T, Gazit S, Yanai H, Shulman S, et al. The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae160
BibTeX
@article{BenTov2025,
author = {Ben-Tov, Amir and Achler, Tomer and Patalon, Tal and Gazit, Sivan and Yanai, Henit and Shulman, Shiri and Assa, Amit},
title = {The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae160}
}
EUVIMED